641 related articles for article (PubMed ID: 33033407)
1. Non-genetic mechanisms of therapeutic resistance in cancer.
Marine JC; Dawson SJ; Dawson MA
Nat Rev Cancer; 2020 Dec; 20(12):743-756. PubMed ID: 33033407
[TBL] [Abstract][Full Text] [Related]
2. Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.
Biswas A; De S
Am J Physiol Cell Physiol; 2021 May; 320(5):C750-C760. PubMed ID: 33657326
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-driven intratumor heterogeneity and immune evasion.
Terry S; Engelsen AST; Buart S; Elsayed WS; Venkatesh GH; Chouaib S
Cancer Lett; 2020 Nov; 492():1-10. PubMed ID: 32712233
[TBL] [Abstract][Full Text] [Related]
4. Emerging insights of tumor heterogeneity and drug resistance mechanisms in lung cancer targeted therapy.
Lim ZF; Ma PC
J Hematol Oncol; 2019 Dec; 12(1):134. PubMed ID: 31815659
[TBL] [Abstract][Full Text] [Related]
5. Lineage plasticity in cancer: a shared pathway of therapeutic resistance.
Quintanal-Villalonga Á; Chan JM; Yu HA; Pe'er D; Sawyers CL; Sen T; Rudin CM
Nat Rev Clin Oncol; 2020 Jun; 17(6):360-371. PubMed ID: 32152485
[TBL] [Abstract][Full Text] [Related]
6. The great escape: tumour cell plasticity in resistance to targeted therapy.
Boumahdi S; de Sauvage FJ
Nat Rev Drug Discov; 2020 Jan; 19(1):39-56. PubMed ID: 31601994
[TBL] [Abstract][Full Text] [Related]
7. Persister cell plasticity in tumour drug resistance.
McDonald PC; Dedhar S
Semin Cell Dev Biol; 2024 Mar; 156():1-10. PubMed ID: 37977107
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Plasticity in Melanoma Progression and Response to Oncogene Targeted Therapies.
Alkaraki A; McArthur GA; Sheppard KE; Smith LK
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830962
[TBL] [Abstract][Full Text] [Related]
9. Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance.
Bhat GR; Sethi I; Sadida HQ; Rah B; Mir R; Algehainy N; Albalawi IA; Masoodi T; Subbaraj GK; Jamal F; Singh M; Kumar R; Macha MA; Uddin S; Akil ASA; Haris M; Bhat AA
Cancer Metastasis Rev; 2024 Mar; 43(1):197-228. PubMed ID: 38329598
[TBL] [Abstract][Full Text] [Related]
10. The emergence of drug resistance to targeted cancer therapies: Clinical evidence.
Sarmento-Ribeiro AB; Scorilas A; Gonçalves AC; Efferth T; Trougakos IP
Drug Resist Updat; 2019 Dec; 47():100646. PubMed ID: 31733611
[TBL] [Abstract][Full Text] [Related]
11. The Transcriptional and Epigenetic Landscape of Cancer Cell Lineage Plasticity.
Davies A; Zoubeidi A; Beltran H; Selth LA
Cancer Discov; 2023 Aug; 13(8):1771-1788. PubMed ID: 37470668
[TBL] [Abstract][Full Text] [Related]
12. The pan-therapeutic resistance of disseminated tumor cells: Role of phenotypic plasticity and the metastatic microenvironment.
Ma B; Wells A; Clark AM
Semin Cancer Biol; 2020 Feb; 60():138-147. PubMed ID: 31376430
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer.
Ravindran Menon D; Hammerlindl H; Torrano J; Schaider H; Fujita M
Theranostics; 2020; 10(14):6261-6277. PubMed ID: 32483452
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies.
Shi ZD; Pang K; Wu ZX; Dong Y; Hao L; Qin JX; Wang W; Chen ZS; Han CH
Signal Transduct Target Ther; 2023 Mar; 8(1):113. PubMed ID: 36906600
[TBL] [Abstract][Full Text] [Related]
15. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
16. Immuno-oncology from the perspective of somatic evolution.
González S; Volkova N; Beer P; Gerstung M
Semin Cancer Biol; 2018 Oct; 52(Pt 2):75-85. PubMed ID: 29223477
[TBL] [Abstract][Full Text] [Related]
17. Genetic and non-genetic drug resistance: Darwin or Lamarck?
Russo M
Mol Oncol; 2024 Feb; 18(2):241-244. PubMed ID: 38308461
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion.
Friedmann Angeli JP; Krysko DV; Conrad M
Nat Rev Cancer; 2019 Jul; 19(7):405-414. PubMed ID: 31101865
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of acquired tumor drug resistance.
Aleksakhina SN; Kashyap A; Imyanitov EN
Biochim Biophys Acta Rev Cancer; 2019 Dec; 1872(2):188310. PubMed ID: 31442474
[TBL] [Abstract][Full Text] [Related]
20. Mathematical models of cell phenotype regulation and reprogramming: Make cancer cells sensitive again!
Wooten DJ; Quaranta V
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):167-175. PubMed ID: 28396217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
